Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult Volunteers

A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

(2013) Aristine Cheng et al.   VACCINE

Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates

(2012) Ai-Hsiang Chou et al.   PLoS One

Production of EV71 vaccine candidates

(2012) Pele Chong et al.   Human Vaccines & Immunotherapeutics

Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children

(2012) Fan-Yue Meng et al.   Human Vaccines & Immunotherapeutics

Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates

(2011) Hsuen-Wen Chang et al.   JOURNAL OF VIROLOGICAL METHODS

Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection

(2011) Emily Jane Bek et al.   VACCINE

Identification and characterization of a cross-neutralization epitope of Enterovirus 71

(2011) Chia-Chyi Liu et al.   VACCINE

Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys

(2011) Chenghong Dong et al.   VACCINE

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

(2011) Jui-Yuan Chang et al.   VACCINE

Development of enterovirus 71 vaccines

(2010) Min-Shi Lee et al.   Expert Review of Vaccines

Virology, epidemiology, pathogenesis, and control of enterovirus 71

(2010) Tom Solomon et al.   LANCET INFECTIOUS DISEASES

Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences

(2009) Yoke-Fun Chan et al.   INFECTION GENETICS AND EVOLUTION

Reemergence of Enterovirus 71 in 2008 in Taiwan: Dynamics of Genetic and Antigenic Evolution from 1998 to 2008

(2009) S.-W. Huang et al.   JOURNAL OF CLINICAL MICROBIOLOGY